Full index of posts »
Latest Comments
-
Walters1022 on Virnetx Has A Lot Going On Behind The Scenes Raised over $4 billion for early stage cos incl...
-
John H. Ford on VHC's new patent provides leverage in potential buyout negotiations. Nothing has changed materially within the compa...
-
haikman on VHC's new patent provides leverage in potential buyout negotiations. what do you think of VHC now?
-
Norril on Virnetx article correction Thanks for the clarification John. Been quite a...
-
buy4long on Insmed up over 100% in three months This research, if it exists, is a product for w...
Most Commented
- VHC's new patent provides leverage in potential buyout negotiations. (8 Comments)
- An Oculus Shareholder Investigates Their Veterinary Business (4 Comments)
- Insmed up over 100% in three months (4 Comments)
- Kodak could double or drop in half by June 23 (3 Comments)
- VHC, potentially huge payoff in 2011 (2 Comments)
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.












View John H. Ford's Instablogs on:
Isoray Featured On Discovery Channel
For those of you who have been following Isoray, an important video was just aired on the Discovery Channel, featuring Isoray's lead product, cesium 131. Here is the link:
http://link.brightcove.com/services/player/bcpid1501665922001?bckey=AQ~~,AAAAAAABkyc~,PFOoGLfSWhaAwp3PhcPV3VgWFY-uqT1m&bctid=1642707491001
if you're not familiar with the benefits of cesium 131 for treating prostate cancer, read this article:
http://seekingalpha.com/article/308614-isoray-impressive-98-success-treating-prostate-cancer
What I like about the video, is that somehow the Discovery Channel "discovered" Isoray's product, and decided to do a story.
In my opinion, cesium 131 will eventually become the industry standard for treating prostate cancer, and Isoray will benefit tremendously. It just takes a while, and videos like this will help tremendously. If doctors are resistant to making the switch to cesium 131, patients will certainly begin to pressure them.
Also, today Isoray announced the company has earned the European CE Mark, allowing for immediate sales of the company's GliaSite products in 31 European countries. This will definitely have a positive affect on top line revenue. Once again, Isoray's CEO, Dwight Babcock continues to impress me with his execution.
For all you Virnetx investors who were able to buy Isoray shares at $.40 last month, congratulations.
Disclosure: I am long ISR.
Markman Ruling Favorable For Virnetx
Here is the link:
http://www.investorvillage.com/uploads/81835/files/266-042512.pdf
Virnetx prevailed on some important key points, and I believe the company will release a statement later today. According to my sources, Virnetx is in a very strong position right now. As per Judge Davis's order, I expect settlement negotiations to commence.
Disclosure: I am long VHC.
Virnetx Has A Lot Going On Behind The Scenes
For all you Virnetx fans, here's an interesting read:
http://www.investorvillage.com/uploads/81835/files/129-042412.pdf
After reading a good part of the document, my general impression was that the defendants are certainly not coming from a position of strength. Basically they are just whining.
I was amazed that one of the defendants presented over 7 million pages of documents. Can you imagine reading 7 million pages?
In terms of the Markman, the preliminary decision is definitely taking longer than I expected. I was fortunate to sell my April calls at a 300% profit, due largely to Jim Cramer's positive comments on Virnetx. I'm now holding common shares and January calls. Depending on market activity, I may buy more calls.
Disclosure: I am long VHC.